Mechanisms and Treatment of Intradialytic Hypertension - Sodium

NCT01371890 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2020-12-21

No results posted yet for this study

Summary

The purpose of this study is to determine the role of dialysate exposure and fluid removal during hemodialysis in the pathophysiology of intradialytic hypertension.

Conditions

  • Hemodialysis
  • End-stage Renal Disease
  • Hypertension
  • Intradialytic Hypertension

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Jula K Inrig, MD, MHS · UT Southwestern Medical Center

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01371890 on ClinicalTrials.gov